Insmed Overview
Insmed Target Price
Analysts' average 12-month price target for Insmed is $190.
Get informed when a big investor buys or sells
+ FollowShare Price
$126.33
Average Target Price
$194.00
53.6% upside
53.6% upside15 analysts in the last 4 months
High: $235 | Low: $160
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-07 | Morgan Stanley | $218 | 72.6% upside |  |
| 2026-08-07 | Evercore ISI | $170 | 34.6% upside | |
| 2026-08-07 | Guggenheim | $205 | 62.3% upside | |
| 2026-08-07 | UBS | $172 | 36.2% upside | |
| 2026-08-07 | Wells Fargo | $169 | 33.8% upside | |
| 2026-08-06 | Jefferies | $175 | 38.5% upside | |
| 2026-07-28 | Cantor FitzgeraldOlivia Brayer | $235 | 86% upside | |
| 2026-07-20 | BMO CapitalConor MacKay | $192 | 52% upside | |
| 2026-07-20 | H.C. WainwrightAndrew Fein | $220 | 74.1% upside | |
| 2026-07-15 | Wells Fargo | $161 | 27.4% upside | |
| 2026-06-16 | Mizuho SecuritiesGraig Suvannavejh | $192 | 52% upside | |
| 2026-05-13 | Truist Financial | $185 | 46.4% upside | |
| 2026-05-08 | Wells Fargo | $160 | 26.7% upside | |
| 2026-05-08 | GuggenheimVamil Divan | $226 | 78.9% upside | |
| 2026-04-16 | Guggenheim | $230 | 82.1% upside | |
| 2026-04-14 | RBC Capital | $216 | 71% upside | |
| 2026-04-10 | Raymond James | $200 | 58.3% upside | |
| 2026-04-08 | Mizuho Securities | $202 | 59.9% upside | |
| 2026-03-26 | H.C. Wainwright | $245 | 93.9% upside | |
| 2026-02-24 | Mizuho Securities | $204 | 61.5% upside | |
| 2026-02-20 | Morgan Stanley | $166 | 31.4% upside | |
| 2026-02-20 | Wells FargoTiago Fauth | $208 | 64.6% upside | |
| 2026-02-19 | Stifel Nicolaus | $205 | 62.3% upside | |
| 2026-02-19 | Mizuho SecuritiesGraig Suvannavejh | $211 | 67% upside | |
| 2026-01-27 | BarclaysEliana Merle | $231 | 82.9% upside | |
| 2026-01-22 | Roth Capital | $212 | 67.8% upside | |
| 2026-01-21 | RBC CapitalLeonid Timashev | $200 | 58.3% upside | |
| 2026-01-12 | Truist FinancialDanielle Brill | $205 | 62.3% upside | |
| 2026-01-08 | Morgan StanleyMaxwell Skor | $157 | 24.3% upside | |
| 2026-01-06 | UBS | $215 | 70.2% upside | |
| 2025-12-19 | Truist FinancialDanielle Brill | $202 | 59.9% upside | |
| 2025-12-18 | H.C. Wainwright | $230 | 82.1% upside | |
| 2025-12-18 | Cowen & Co. | $241 | 90.8% upside | |
| 2025-12-18 | Mizuho SecuritiesGraig Suvannavejh | $212 | 67.8% upside | |
| 2025-12-18 | Guggenheim | $221 | 74.9% upside | |
| 2025-12-18 | Wedbush | $203 | 60.7% upside | |
| 2025-12-18 | RBC CapitalLeonid Timashev | $195 | 54.4% upside | |
| 2025-12-18 | Wells Fargo | $195 | 54.4% upside | |
| 2025-12-18 | Wolfe ResearchAndy Chen | $167 | 32.2% upside | |
| 2025-12-16 | Wells FargoTiago Fauth | $234 | 85.2% upside | |
| 2025-12-16 | Cantor FitzgeraldOlivia Brayer | $230 | 82.1% upside | |
| 2025-12-10 | Jefferies | $269 | 112.9% upside | |
| 2025-12-04 | Redburn Partners | $263 | 108.2% upside | |
| 2025-12-01 | Mizuho SecuritiesGraig Suvannavejh | $256 | 102.6% upside | |
| 2025-10-31 | Goldman Sachs | $225 | 78.1% upside | |
| 2025-10-31 | RBC CapitalLeonid Timashev | $215 | 70.2% upside | |
| 2025-10-31 | UBSTrung Huynh | $223 | 76.5% upside | |
| 2025-10-31 | Wells Fargo | $217 | 71.8% upside | |
| 2025-10-29 | Mizuho SecuritiesGraig Suvannavejh | $196 | 55.1% upside | |
| 2025-10-28 | Cantor Fitzgerald | $192 | 52% upside | |